Ilan Daskal
Known title: EVP, Chief Financial OfficerCIK: 0001446964
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Transaction History
| VIAV | ▲ Buy | Option Exercise | 82,671 | $0 | 9/22/2026 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 37,285 | $1.4M | 9/22/2026 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 71,127 | $0 | 9/22/2026 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 32,079 | $1.2M | 9/22/2026 | View on chart |
| VIAV | ▼ Sell | Open Market | 30,257 | $1.1M | 8/31/2026 | View on chart |
| VIAV | ▼ Sell | Open Market | 26,033 | $945K | 8/31/2026 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 55,114 | $0 | 8/28/2026 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 24,857 | $908K | 8/28/2026 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 47,420 | $0 | 8/28/2026 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 21,387 | $781K | 8/28/2026 | View on chart |
| VIAV | ▼ Sell | Open Market | 25,100 | $448K | 12/2/2025 | View on chart |
| VIAV | ▼ Sell | Open Market | 39,709 | $692K | 12/2/2025 | View on chart |
| VIAV | ▼ Sell | Open Market | 105,191 | $1.8M | 12/2/2025 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 65,944 | $0 | 11/28/2025 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 29,741 | $534K | 11/28/2025 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 37,879 | $0 | 11/28/2025 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 17,084 | $306K | 11/28/2025 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 62,645 | $0 | 11/28/2025 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 28,253 | $507K | 11/28/2025 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 35,984 | $0 | 11/28/2025 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 16,229 | $291K | 11/28/2025 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 70,545 | $0 | 9/23/2025 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 31,816 | $395K | 9/23/2025 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 55,115 | $0 | 8/28/2025 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 24,857 | $280K | 8/28/2025 | View on chart |
| VIAV | ▼ Sell | Open Market | 82,095 | $762K | 6/4/2025 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 39,783 | $0 | 11/28/2024 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 20,162 | $199K | 11/28/2024 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 22,851 | $0 | 11/28/2024 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 11,581 | $114K | 11/28/2024 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 65,944 | $0 | 11/28/2024 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 33,421 | $330K | 11/28/2024 | View on chart |
| VIAV | ▲ Buy | Option Exercise | 37,879 | $0 | 11/28/2024 | View on chart |
| VIAV | ▼ Sell | Tax Withholding | 19,198 | $190K | 11/28/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 542 | $0 | 9/2/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 269 | $106K | 9/2/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 694 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 240 | $95K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 456 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 209 | $82K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 700 | $0 | 4/8/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 243 | $113K | 4/8/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 541 | $0 | 9/2/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 269 | $129K | 9/2/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 455 | $0 | 9/1/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 226 | $110K | 9/1/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 700 | $0 | 4/8/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 257 | $153K | 4/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
VIAV Highlights New 100G Testing Platform and CF50 Product
Viavi Solutions highlighted its latest 100G testing platform and the CF50 product in recent releases, signaling a push into enterprise‑scale and AI inference markets. A Yahoo article noted the company’s more than threefold growth over the past year, while a Q2 review compared its performance to peers. These updates underscore Viavi’s ongoing expansion in high‑speed testing technology.
VIAV Highlights New 100G Testing Platform and CF50 Product. Viavi Solutions highlighted its latest 100G testing platform and the CF50 product in recent releases, signaling a push into enterprise‑scale and AI inference markets. A Yahoo article noted the company’s more than threefold growth over the past year, while a Q2 review compared its performance to peers. These updates underscore Viavi’s ongoing expansion in high‑speed testing technology.